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the same imaging dose to the patient. The objective of the 
present study was to investigate the effect of using different 
pulse current and time combinations for CBCT acquisition, 
and provide local guidelines on how to choose the x-ray 
current/time. 
Materials and Methods: All CBCT scans were acquired on 
Elekta Synergy or Versa HD accelerators equipped with the 
XVI 4.5 CBCT system. Three series of 200 projection images 
were acquired without a phantom on the treatment couch, 
using different combinations of pulse current and time to 
provide an x-ray intensity of 0.4 mAs per projection image. 
All three series were acquired at 120 kVp with the S20 F0 
filter combination. The pulse current/time combinations 
were 10mA/40ms, 20mA/20ms and 40mA/10ms. 
To further investigate the potential effect on the 
reconstructed image quality, two CBCT scans of a cylindrical 
water phantom (20 cm diameter, 48 cm length) were 
acquired at 120kVp using the S20 F0 filter combination. 200 
frames were acquired over an arc of 200 degrees, and 
projection images were exposed to 10mA/40ms in the first 
scan and 40mA/10ms in the second scan. 
Results: Plotting the mean signal in each projection image of 
the open scans as a function of projection image number 
revealed that the shorter pulse times had larger signal 
variation between the projection images. On top of this, a 
series of sudden spikes was observed for the 10ms pulse time, 
and these were completely removed when using the 40ms 
pulse times. The latter, more consistent x-ray output from 
the generator will in theory provide a less noisy CBCT 
reconstruction. Reconstructions of the two scans of the water 
cylinder are shown in the figure below. It is evident that 
homogeneity and image noise is reduced when using the long 
pulse time compared to the short pulse time. These effects 
are most substantial towards the outer edges of the 
reconstructed volume, where the undersampling of the data 
required for reconstruction becomes more severe. 
 
 
Conclusions: The use of longer pulse times and lower pulse 
currents when acquiring CBCT projection images was found to 
improve image quality in the reconstructed CBCT volume. 
Based on this finding, our clinical CBCT acquisition protocols 
were changed to use the longest possible x-ray pulse times 
while keeping the imaging dose the same as before this 
study. We have not observed a significant improvement in 
image quality of patient CBCTs, possibly because there are 
other more severe sources of image noise in the system. The 
change to longer pulse times is however a quick fix in 
changing the acquisition protocols once, and does not 
increase the CBCT scan time as the x-ray pulse time remains 
much shorter than the frame time of the XVI system. 
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Purpose/Objective: The target of this study is to evaluate 
the accuracy of the dose distribution calculation based on the 
CBCT by converting the pixel values using a histogram of 
pixel values of the simulation CT and CBCT. 
Materials and Methods: The simulation CT images and the 
CBCT images just before treatment of 10 prostate cancer 
patients have been acquired. It is not sufficient to calculate 
the dose distribution directly using the pixel values of the 
CBCT, because of insufficient calibration of the pixel values 
in the CBCT. The pixel values in the CBCT images were 
converted using an in-house program. Original treatment 
plans consisting of seven fields were created on the 
simulation CT images. These plans were applied to the CBCT 
images and the dose distributions were re-calculated with 
same monitor units (MUs). These dose distributions were 
compared with original dose distributions. 
Results: The results of the pixel value conversion were as 
follows. The mean differences of pixel values for the 
prostate, subcutaneous adipose, muscle and right-femur were 
-10.78±34.60, 11.78±41.06, 29.49±36.99 and 0.14±31.15, 
respectively. In the results of the re-calculated dose 
distributions, the mean differences of prescription doses for 
seven fields were 4.13±0.95%, 0.34±0.86%, -0.05±0.55%, 
1.35±0.98%, 1.77±0.56%, 0.89±0.69% and 1.69±0.71% 
respectively. As a whole, the difference of prescription dose 
was 1.54±0.4%. 
Conclusions: The dose distribution re-calculation on the 
CBCT images achieves an accuracy of <2% by using an in-
house program to convert pixel values. This method may be 
able to efficiently allow the implementation of adaptive 
radiation therapy. 
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Purpose/Objective: This study aims to quantify the organ 
and effective doses from BrainLab ExacTrac x-ray exposures 
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during cranium, head and neck, thorax and prostate imaging 
using PCXMC, a Monte Carlo computer program. The organ 
doses will be compared with published organ doses resulting 
from cone-beam CT and MV planar imaging. 
Materials and Methods: The half-value layer, total filtration, 
radiation output and peak kilovoltage of the x-ray beams 
were measured using an Unfors Xi meter. Entrance dose, 
entrance field-size and focus to skin distance were calculated 
for each clinical protocol and used as input to PCXMC 
simulations. Clinically-representative beam directions and 
angles were used. Absorbed dose to each simulated organ 
and effective dose were calculated from a pair of ExacTrac 
exposures for each anatomical protocol. 
Results: The maximum organ dose was 0.4 mGy to the 
kidneys from the prostate protocol. The maximum effective 
dose of 0.1 mSv was also from the prostate protocol. The 
maximum organ dose from a pair of ExacTrac images is 
between 27 and 128 times lower than published organ doses 
resulting from a single cone-beam computed tomography 
scan, and 250 times lower than doses from a single MV 
planar-imaging procedure published in the literature. 
Conclusions: This study has shown that PCXMC can be used to 
estimate organ and effective doses from ExacTrac use. Organ 
doses from ExacTrac are low compared with those from cone-
beam CT and MV planar-imaging. 
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Purpose/Objective: The presence of dental implants or 
fillings affects the image quality of the planning-CT (pCT) of 
head and neck (H&N) patients by causing scatter and beam 
hardening artifacts. These artifacts can cause inaccuracies in 
the dose calculation of the radiation therapy treatment plan, 
in particular if a deterministic dose calculation algorithm is 
used (Acuros XB [AXB; Varian Medical Systems Inc., Palo Alto, 
USA]).  
A recent commercially released CT reconstruction algorithm 
(MAR; General Electric, Milwaukee, USA) greatly reduces 
metal artifacts and thus hypothetically improves the 
accuracy of the dose calculation for patients with dental 
fillings or implants. 
Applying a density override (DO) for the scatter regions is 
another often used solution to reduce the influence of metal 
artifacts on the dose calculation. We studied the effect of 
density overrides, the use of MAR and the combination of 
both on the dose distribution for H&N cancer patients with 
dental fillings treated with RapidArc (RA) radiotherapy. 
Materials and Methods: For five H&N cancer patients with 
dental implants and/or fillings near the location of the tumor 
an additional MAR-CT reconstruction was acquired after the 
pCT was obtained. For each patient 4 different datasets were 
generated: 1)pCT without DO; 2)pCT with DO; 3)MAR-CT 
without DO; 4)MAR-CT with DO. Dataset 4 was used as the 
reference dataset. For each dataset a treatment plan was 
created using our standard clinical optimization protocol and 
calculated on the reference dataset using AXB. 
For all plans DVH parameters (Dmax, Dmean, D2%, D98% and the 
V95%) for PTVboost and PTVscatter, which represents only that part 
of the PTVboost which is affected by scatter, were reported 
and compared to those of the reference dataset. Also, 
differences in dose to the OAR, the ipsi- and contra-lateral 
parotid gland and the contra-lateral submandibular gland 
were reported in terms of Dmax, Dmean and D2%. 
Results: Preliminary results for 1 patient show limited 
differences in PTV coverage between the 3 datasets and the 
reference dataset. The Dmax of the PTVboost differed 1% at 
most, and the PTVscatter shows an increase in Dmax of 1.4% for 
the treatment plan based on the pCT without DO (Table 1, 
Figure 1). Larger differences were found for the OAR’s. The 
Dmean of the contralateral submandibular gland was found to 
be 47 cGy, 90 cGy and 170 cGy higher for dataset 3, 1 and 2 
respectively. 
 
Table 1: Dose information pCT without DO and percentage 
difference compared to MAR-CT with DO 
 
 
Figure 1: Planning-CT (left) and MAR-CT reconstruction (right) 
visualized with the contoured GTV (blue) , CTVboost (green) 
and PTVboost (red) , and both parotid glands (purple and lime).  
 
Conclusions: Although there is an increase in mean dose of 
the OAR’s when MAR, a density override or a combination of 
both is omitted, the differences in dose distribution between 
the several methods are small and not clinically relevant. 
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Purpose/Objective: The objective of the ARTFiBio project is 
to establish an integrated information network from which 
they can develop predictive models of tumour response based 
on functional data in vivo and to share datasets, and 
registration and predictive tools with the scientific 
community. 
In order to relate information from multiple imaging 
modalities ( PET, CT y MRI) at different stages of treatment 
(through time) a robust registration scheme is critical. We 
present results of a comparison ARTFIBio tools with the 
